Scholars Central

Research articlePublished 11 Feb 2019

A Small Prospective Randomized Doubleblind Placebo Controlled Trial Evaluating The Efficacy Of Postoperative Use Of Elas

Authors: Francis J Deasis, Brittany Lapin, Matthew E Gitelis, John G Linn, Woody Denham, Stephen P Haggerty, Joann M Carbray, Michael B Ujiki

Journal of Clinical Anesthesiology: Open Access

Volume 3 · Issue 1 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Objective: Laparoscopic Ventral Hernia Repair (LVHR) can result in significant postoperative pain. Elastomeric pain pump devices may reduce pain and narcotic medication use postoperatively. We present a prospective randomized double-blind placebo-controlled trial evaluating device efficacy in LVHR patients. Methods: Pumps were preperitoneally placed in LVHR patients, and a 4-day continuous bupivacaine or saline infusion (4 ml/hour) was given. Demographics, intra/postoperative information, and quality-of-life were compared between groups using chisquare test, t-test, and Mann-Whitney-U test. Quality-of-life consisted of pre/postoperative Short Form-36 surveys and 7-day self-reported pain and medication logs. Results: Twenty-nine LVHR patients received pumps: 17 (59%) with bupivacaine and 12 (41%) with saline. There was no difference in demographic and intraoperative variables. Mesh size was larger for saline patients compared to bupivacaine patients (median 429 vs 225 cm2, p=0.05). There was no difference in length-of-stay or complications. Discharge pain scores were worse for saline patients versus those receiving bupivacaine (median (q1,q3): 4 (2,5) vs 2 (0,3), p=0.064). Ketorolac use was higher in saline patients (p=0.01), and saline patients used pain medication longer (median (q1, q3) 9 (7,10) vs 6 (4,8), p=0.05). Other narcotic and non-narcotic use did not differ. Pain and medication logs showed significantly worse self-reported pain and pain management for the saline group versus the bupivacaine group on days 1-4 (p<0.05), with no differences reported after day 4. There were no differences in quality-of-life scores preoperatively or at 3 weeks postoperative. Conclusion: In this prospective randomized double-blind placebo-controlled trial, we found less pain at discharge, fewer days on pain medications, and less self-reported pain in patients receiving bupivacaine versus saline. However there was no significant reduction in most narcotic and non-narcotic medication use and no postoperative improvements in quality-of-life for LVHR patients using pumps. Larger studies investigating bupivacaine and other alternatives for reducing postoperative pain after LVHR are needed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Anesthesiology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Anesthesiology: Open Access
  • SubjectAnaesthesia & Pain
  • BylineArticles whose byline prints “Francis J Deasis”
  • BylineArticles whose byline prints “Brittany Lapin”
  • BylineArticles whose byline prints “Matthew E Gitelis”
  • BylineArticles whose byline prints “John G Linn”
  • BylineArticles whose byline prints “Woody Denham”
  • BylineArticles whose byline prints “Stephen P Haggerty”
  • BylineArticles whose byline prints “Joann M Carbray”
  • BylineArticles whose byline prints “Michael B Ujiki”